Session 1
Dr. Hebah Alhajeri
Read More
Consultant Rheumatologist Mubarak AlKabeer Hospital
President of Kuwait Association of Rheumatologists
Dr. Laurent Arnaud
Read More
Pr Laurent ARNAUD, MD, PhD.
Laurent.arnaud@chru-strasbourg.fr
Twitter: Lupusreference
Laurent ARNAUD (MD, PhD) is full Professor of Rheumatology at Strasbourg University & Academic Hospitals, France. His main clinical interests focus on the care of patients with Systemic Lupus Erythematosus (SLE). He is leading a research group focusing on innovative strategies for holistic SLE care using novel diagnostic and therapeutic digital strategies. With his team at the French National Reference Center for Rare Autoimmune Diseases of Strasbourg (CRMR RESO), he has published more than 300 articles in the field of rare diseases and is currently leading several international taskforces such as the Treat-to-target (T2T) taskforce and the SLICC/ReCONNET/SLEuro recommendations for rare manifestations in SLE. Professor Arnaud is the President of the European Lupus Society (SLEuro) and Disease Coordinator for Lupus and Relapsing polychondritis of the European Reference Network for rare diseases ReCONNET. He is the curator of a X/twitter account (@Lupusreference) about lupus education, followed by >17k people.
Dr. Christopher Denton
Read More
Christopher Denton PhD FRCP FMedSci
Professor of Experimental Rheumatology at University College London (UCL) Division of Medicine and Honorary Consultant Rheumatologist at the Royal Free Hospital in London, U.K.
Professor Denton is an international expert on systemic sclerosis (scleroderma) with over 500 peer reviewed publications. His scleroderma programme at the Royal Free Hospital cares for more than 1500 patients. He has led international projects on renal crisis, pulmonary hypertension, and interstitial lung disease. He led publication of the 2024 British Society for Rheumatology (BSR) systemic sclerosis management guideline.
Dr. Sindhu Johnson
Read More
Sindhu R. Johnson MD PhD
Dr Johnson is a Professor of Medicine at the University of Toronto and is Director of the Toronto Scleroderma Program. She is Director of the Clinical Epidemiology Program at the Dalla Lana School of Public Health, University of Toronto, Canada.
Dr Johnson has published >260 articles in peer reviewed journals, secured $7 million dollars in salary support and operating grant funding, published 5 book chapters, and invited to 4 Editorial Boards. She has supervised 20 international clinical research fellows and graduate students, most of whom have established Scleroderma Programs or have academic appointments in their home countries. Dr Johnson has led collaborations between the American College of Rheumatology and the European League Against Rheumatism for the development of classification criteria for systemic sclerosis and systemic lupus erythematosus. She has been a site investigator for the first two FDA approved medications (nintedinib, tocilizumab) for scleroderma associated interstitial lung disease (ILD). She is the Principal Investigator for the American College of Rheumatology, American College of Chest Physicians guidelines for the screening, monitoring, and treatment of ILD in the systemic autoimmune rheumatic diseases.
Session 2
Dr. Laurent Arnaud
Read More
Pr Laurent ARNAUD, MD, PhD.
Laurent.arnaud@chru-strasbourg.fr
Twitter: Lupusreference
Laurent ARNAUD (MD, PhD) is full Professor of Rheumatology at Strasbourg University & Academic Hospitals, France. His main clinical interests focus on the care of patients with Systemic Lupus Erythematosus (SLE). He is leading a research group focusing on innovative strategies for holistic SLE care using novel diagnostic and therapeutic digital strategies. With his team at the French National Reference Center for Rare Autoimmune Diseases of Strasbourg (CRMR RESO), he has published more than 300 articles in the field of rare diseases and is currently leading several international taskforces such as the Treat-to-target (T2T) taskforce and the SLICC/ReCONNET/SLEuro recommendations for rare manifestations in SLE. Professor Arnaud is the President of the European Lupus Society (SLEuro) and Disease Coordinator for Lupus and Relapsing polychondritis of the European Reference Network for rare diseases ReCONNET. He is the curator of a X/twitter account (@Lupusreference) about lupus education, followed by >17k people.
Dr. Sindhu Johnson
Read More
Sindhu R. Johnson MD PhD
Dr Johnson is a Professor of Medicine at the University of Toronto and is Director of the Toronto Scleroderma Program. She is Director of the Clinical Epidemiology Program at the Dalla Lana School of Public Health, University of Toronto, Canada.
Dr Johnson has published >260 articles in peer reviewed journals, secured $7 million dollars in salary support and operating grant funding, published 5 book chapters, and invited to 4 Editorial Boards. She has supervised 20 international clinical research fellows and graduate students, most of whom have established Scleroderma Programs or have academic appointments in their home countries. Dr Johnson has led collaborations between the American College of Rheumatology and the European League Against Rheumatism for the development of classification criteria for systemic sclerosis and systemic lupus erythematosus. She has been a site investigator for the first two FDA approved medications (nintedinib, tocilizumab) for scleroderma associated interstitial lung disease (ILD). She is the Principal Investigator for the American College of Rheumatology, American College of Chest Physicians guidelines for the screening, monitoring, and treatment of ILD in the systemic autoimmune rheumatic diseases.
Dr. Christopher Denton
Read More
Christopher Denton PhD FRCP FMedSci
Professor of Experimental Rheumatology at University College London (UCL) Division of Medicine and Honorary Consultant Rheumatologist at the Royal Free Hospital in London, U.K.
Professor Denton is an international expert on systemic sclerosis (scleroderma) with over 500 peer reviewed publications. His scleroderma programme at the Royal Free Hospital cares for more than 1500 patients. He has led international projects on renal crisis, pulmonary hypertension, and interstitial lung disease. He led publication of the 2024 British Society for Rheumatology (BSR) systemic sclerosis management guideline.
Session 3
| Dr. Adeeba AlHerz |
Read More
Consultant in internal medicine and rheumatology. CEO and clinical director of AdeebaClinic, Kuwait. Graduated from The Faculty of Medicine, Kuwait University in 1993. Had the American and the Canadian Board in Internal Medicine and Rheumatology. Had special training in internal medicine at McGill University in Montreal, Quebec, in general rheumatology at Vancouver University in British Columbia and in lupus and vasculitis at The University of Toronto, Ontario, Canada.
Head of the Kuwait Association of rheumatologists registry group (KAR) and the founder of The Kuwait Registry for Rheumatic Diseases (KRRD).
Has more than 60 researches published in well recognized journals or presented in international conferences.
| Dr. Fatemah Butaiban |
Read More
Head of rheumatology unit at Jaber Alahmed Alsabah hospital, state of Kuwait.
Past president of ArLAR, past president of KAR
Graduate of Kuwait university/ Health science centre 1998, had the certificate of Kuwaiti board of medicine at 2004, followed by MRCP/ London 2004, Kuwait rheumatology fellowship 2008, SCE rheumatology 2010, FRCP/ London 2014
MRCP examiner since 2014
research fellow at Southampton general hospital, rheumatology unit 2007.
clinical tutor for Kuwait medical science centre students and for KIMS post graduate studies.
organised and participated as a speaker in many local and international rheumatology conferences, have published many articles and papers in international journals, and also a reviewer for many international journals in the field of rheumatology.
| Dr. Khaled Aldoub |
Read More
Membership of the Royal College of Physicians (MRCP-UK) 2015
Kuwait Institute of Medical Specializations (KIMS): Kuwaiti board of Internal Medicine (KBIM) 2016
Joined the London Behcet’s Centre of Excellence – London UK 2019-2020
Specialty certificate exam (SCE – UK) in Rheumatology 2020
Fellowship in Rheumatology at Bart’s Health NHS Trust & Royal London Hospital – London UK 2021
Certified for Muskloskletal Ultrasound in diagnostic and guided injections – Royal London Hospital – London UK 2021
Vice President of Kuwait Association of Rheumatologists (KAR) 2023
Senior Specialist in Internal Medicine and Rheumatology, Farwaniya Hospital
| Dr. Yaser Ghadanfar |
Read More
Consultant in Adult Rheumatology and Clinical Immunology and Allergy at Mubarak Al-Kabeer Hospital, Kuwait City.
He graduated from the University of Toronto and held Canadian Board Certificates in Internal Medicine, Adult Rheumatology, and Clinical Immunology & Allergy.
He also holds the American Board in Internal Medicine and Rheumatology.
Dr. Ali is a very active Researcher and has a number of Publications in both the Rheumatology and Allergy fields.
He is a member of several Professional Organisations, including The Royal College of Physicians and Surgeons of Canada (RCPSC) and the American College of Physicians (ACP).
| Dr. Naser Alhadhood |
Read More
Rheumatology consultant in Farwaniya Hospital/Ministry of Health, Kuwait, and Dar Al Shifa Hospital
Bachelor of medicine and surgery (Royal college of surgeons in Ireland (RCSI)
Saudi board of internal medicine (SCFHS)
Saudi fellowship of rheumatology (SCFHS)
RA fellowship (university of Toronto)
Tutor of KBIM
Member of KAR and KMA
Session 4
| Dr. Christian Pagnoux |
Read More
CHRISTIAN PAGNOUX, MD MSc MPH
Dr. Pagnoux trained in internal medicine and clinical immunology in Paris (France). Between 2002 and 2010, he worked in Paris, and has served as vice-president of the French Vasculitis study group. He moved to Toronto (Canada) in 2010, and was appointed in the Division of rheumatology at the Mount Sinai Hospital. He joined the steering committee of the North-American Vasculitis Clinical Research Consortium (VCRC), and founded CanVasc, the Canadian network for research in vasculitis.
He has been involved in many important studies in vasculitis, led by the French, European or North-American groups, has written or co-authored more than 300 peer-reviewed publications and several textbook chapters on vasculitis.
| Dr. Christian Dejaco |
Read More
Head of the Department of Rheumatology of the South Tyrol Health Trust in Italy and Associated Professor at the Medical University Graz, Austria
Long-standing research interest in GCA and PMR
Current program chair of the EULAR conference
Session 5
| Dr. Christian Dejaco |
Read More
Head of the Department of Rheumatology of the South Tyrol Health Trust in Italy and Associated Professor at the Medical University Graz, Austria
Long-standing research interest in GCA and PMR
Current program chair of the EULAR conference
| Dr. Raed Behbehani |
Read More
Raed Behbehani. MD FRCSC
Royal College of Physicians and Surgeons of Canada
Diplomate American Board of Ophthalmology
International fellow of the North American Neuroophthalmological Society
Publication : over 70 peer reviewed articles, 2 book chapters
Session 6
| Dr. Christian Pagnoux |
Read More
CHRISTIAN PAGNOUX, MD MSc MPH
Dr. Pagnoux trained in internal medicine and clinical immunology in Paris (France). Between 2002 and 2010, he worked in Paris, and has served as vice-president of the French Vasculitis study group. He moved to Toronto (Canada) in 2010, and was appointed in the Division of rheumatology at the Mount Sinai Hospital. He joined the steering committee of the North-American Vasculitis Clinical Research Consortium (VCRC), and founded CanVasc, the Canadian network for research in vasculitis.
He has been involved in many important studies in vasculitis, led by the French, European or North-American groups, has written or co-authored more than 300 peer-reviewed publications and several textbook chapters on vasculitis.
| Dr. Christian Dejaco |
Read More
Head of the Department of Rheumatology of the South Tyrol Health Trust in Italy and Associated Professor at the Medical University Graz, Austria
Long-standing research interest in GCA and PMR
Current program chair of the EULAR conference
| Dr. Ahmad Alansari |
Read More
Lt. Col. Dr. Ahmad Alansari is the Head of General Medicine Section at Jaber Al-Ahmad Armed Forces Hospital. His interests span patient satisfaction, physician retention, and education in healthcare. His work also focuses on the potential applications of artificial intelligence in medicine, aiming to improve both patient and physician experience.
Session 7
| Dr. Peter Nash |
Read More
Peter Nash is Professor in the School of Medicine at Griffith University, Queensland, and Director of the Rheumatology Research Unit on the Sunshine Coast.. Prof Nash has Chaired the Professional Affairs Committee and the Therapeutics Committee , the NHMRC musculoskeletal panels and served on the Scientific Advisory Committee of the Australian Rheumatology Association. He is a former member of the Therapeutics Committee of the Australia and New Zealand Bone and Mineral Society. He is a founder member of Grappa and has served on the International Steering Committee for GRAPPA. He is on the editorial board of Annals of the Rheumatic Diseases, RMD Open and the Journal of Rheumatology.
Prof. Nash and his group at the Rheumatology Research Unit have been involved in the pivotal registration clinical trials for all modern targeted and biologic therapies and osteoporosis therapies. He has published more than 300 peer-reviewed papers and 6 book chapters, and has been recognized as rheumatology citation leader of the top 20 rheumatology journals over the last 5 years for 2021-2025. His special interests include metabolic bone disease and novel therapeutics.
| Dr. Salem Almutairi |
Read More
Consultant ophthalmic Surgeon MD, FRCSC.
Fellow Of Royal College of Surgeons And Physicians Of Canada
Head of Uveitis and ocular Inflammation service
Al-Bahar Eye Center.
Graduated From Glasgow medical school – Scotland UK. (HONOR)
Completed residency of ophthalmology program from McGill University Montreal – Canada.
Completed Fellowship in Cornea, External disease, uveitis and immunology – McGill University.
Assistant program director of Kuwait Residency program of ophthalmology – 2010 – 2014.
Program director of Kuwait Residency program of ophthalmology (2014 – 2022).
Session 8
| Dr. Peter Nash |
Read More
Peter Nash is Professor in the School of Medicine at Griffith University, Queensland, and Director of the Rheumatology Research Unit on the Sunshine Coast.. Prof Nash has Chaired the Professional Affairs Committee and the Therapeutics Committee , the NHMRC musculoskeletal panels and served on the Scientific Advisory Committee of the Australian Rheumatology Association. He is a former member of the Therapeutics Committee of the Australia and New Zealand Bone and Mineral Society. He is a founder member of Grappa and has served on the International Steering Committee for GRAPPA. He is on the editorial board of Annals of the Rheumatic Diseases, RMD Open and the Journal of Rheumatology.
Prof. Nash and his group at the Rheumatology Research Unit have been involved in the pivotal registration clinical trials for all modern targeted and biologic therapies and osteoporosis therapies. He has published more than 300 peer-reviewed papers and 6 book chapters, and has been recognized as rheumatology citation leader of the top 20 rheumatology journals over the last 5 years for 2021-2025. His special interests include metabolic bone disease and novel therapeutics.
| Dr. Shaikhah Al-Abdulrazzaq |
Read More
Dr. Shaikhah Al-Abdulrazzaq
– Consultant Dermatologist at Al-Salam Hospitals
– European and Kuwaiti Board of Dermatology
– Fellowship in Chronic Inflammatory Skin Diseases from University of Toronto, Canada
– Fellowship in Wound Care from University of Toronto, Canada